In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain

In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain

Source: News-Medical.Net

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19) pandemic.

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19)… [1412 chars]

Read more

Leave a Comment

Your email address will not be published.

0